$1.22
0[0.00%]
At close: Apr 24
$1.20
-0.0200[-1.64%]
After Hours: 9:06AM EDT
ImmunoPrecise Antibodies reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Analyze the earnings history of ImmunoPrecise Antibodies using advanced sorting and filters.
Date | time | ticker | Quarter | Prior EPS | Est EPS | Actual EPS | EPS Surprise | Prior Rev | Est Rev | Actual Rev | Rev Surprise | Get Alert |
---|---|---|---|---|---|---|---|---|---|---|---|---|
07/05/2024 | AM | IPA | Q4 | -$0.15 | — | — | — | $4.15M | — | — | — | Get Alert |
03/14/2024 | AM | IPA | Q3 | -$0.14 | -$0.07 | -$0.08 | -14.29% | $3.84M | $4.50M | $4.55M | 1.22% | Get Alert |
12/14/2023 | AM | IPA | Q2 | -$0.23 | -$0.10 | -$0.07 | 26.00% | $3.90M | $4.33M | $4.62M | 6.74% | Get Alert |
09/14/2023 | AM | IPA | Q1 | -$0.30 | -$0.15 | -$0.10 | 33.33% | $3.65M | $3.94M | $4.26M | 8.17% | Get Alert |
07/07/2023 | AM | IPA | Q4 | $0.17 | -$0.13 | -$0.15 | -15.38% | $4.11M | $4.23M | $4.15M | -1.87% | Get Alert |
03/16/2023 | AM | IPA | Q3 | -$0.16 | -$0.17 | -$0.14 | 17.65% | $3.80M | $3.96M | $3.84M | -3.11% | Get Alert |
12/15/2022 | AM | IPA | Q2 | -$0.21 | — | -$0.23 | — | $3.76M | $3.84M | $3.90M | 1.51% | Get Alert |
09/14/2022 | AM | IPA | Q1 | -$0.14 | — | -$0.30 | — | $3.73M | $4.02M | $3.65M | -9.33% | Get Alert |
07/29/2022 | AM | IPA | Q4 | -$0.29 | — | $0.17 | — | $4.88M | $4.48M | $4.11M | -8.37% | Get Alert |
03/16/2022 | AM | IPA | Q3 | — | -$0.13 | -$0.16 | -23.08% | — | $4.14M | $3.80M | -8.16% | Get Alert |
12/13/2021 | AM | IPA | Q2 | — | — | -$0.21 | — | — | — | $3.76M | — | Get Alert |
09/09/2021 | AM | IPA | Q1 | — | — | -$0.14 | — | — | — | $3.73M | — | Get Alert |
07/28/2021 | PM | IPA | Q4 | -$0.01 | — | -$0.29 | — | $4.15M | — | $4.88M | — | Get Alert |
ImmunoPrecise Antibodies (IPA) is scheduled to report earnings on July 5, 2024. The last reported earnings were for reported on March 14, 2024 for Q3.
The Actual EPS was $-0.08, which missed the estimate of $-0.07.
The Actual Revenue was $4.6M, which beat the estimate of $4.5M.
Browse earnings estimates, EPS, and revenue on all stocks.